ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI grants funding: Institute Contemplates Increase In RFA Support Due to Large Number Of Grant Applications

July 9, 1999

California Cancer Research Program Seeks Non-Resident Survivor Reviewers.

May 25, 2001

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

November 18, 1988

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

Las Vegas Cancer Center Cuts Staff, Seeks Lifelines During “Perfect Storm”

May 20, 2011